- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-5968
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2 ; volume:8 ; number:1 ; day:19 ; month:7 ; year:2022 ; pages:1-4 ; date:12.2022
Cell discovery ; 8, Heft 1 (19.7.2022), 1-4, 12.2022
- Urheber
-
Fang, Zhenhao
Peng, Lei
Lucas, Carolina
Lin, Qianqian
Zhou, Liqun
Yang, Luojia
Feng, Yanzhi
Ren, Ping
Renauer, Paul A.
Monteiro, Valter S.
Hahn, Anne M.
Park, Jonathan J.
Zhou, Xiaoyu
Grubaugh, Nathan D.
Wilen, Craig B.
Chen, Sidi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41421-022-00435-w
- URN
-
urn:nbn:de:101:1-2022100120394723918232
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fang, Zhenhao
- Peng, Lei
- Lucas, Carolina
- Lin, Qianqian
- Zhou, Liqun
- Yang, Luojia
- Feng, Yanzhi
- Ren, Ping
- Renauer, Paul A.
- Monteiro, Valter S.
- Hahn, Anne M.
- Park, Jonathan J.
- Zhou, Xiaoyu
- Grubaugh, Nathan D.
- Wilen, Craig B.
- Chen, Sidi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants